Rheinbach, Germany

Klaus-Juergen Steffens

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus-Juergen Steffens. Retrieved from https://idiyas.com/inventor/klaus-juergen-steffens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus-Juergen Steffens: Innovator in Oily Suspension Stabilization

Introduction

Klaus-Juergen Steffens is a notable inventor based in Rheinbach, Germany. He has made significant contributions to the field of fluid oil-based suspensions, particularly through his innovative patent.

Latest Patents

Steffens holds a patent titled "Stabilization of oily suspensions comprising hydrophobic silicas." This invention focuses on the stabilization of fluid oil-based suspensions that include hydrophobic silica, along with the development of medicaments based on such suspensions. His work in this area has the potential to enhance the effectiveness and stability of various pharmaceutical formulations.

Career Highlights

Klaus-Juergen Steffens is associated with Bayer Intellectual Property GmbH, where he applies his expertise in the field of chemical engineering and patent development. His role at Bayer has allowed him to contribute to advancements in pharmaceutical technologies.

Collaborations

Steffens has collaborated with notable colleagues, including Iris Heep and Hans-Juergen Hamann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Klaus-Juergen Steffens is a distinguished inventor whose work in stabilizing oily suspensions has made a significant impact in the pharmaceutical industry. His contributions continue to influence the development of effective medicaments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…